share_log

健康元(600380.SH):注射用醋酸曲普瑞林微球新适应症获批

joincare pharmaceutical group industry(600380.SH): 注射用醋酸曲普瑞林微球新适应症获批

Gelonghui Finance ·  10/08 07:08

joincare pharmaceutical group industry (600380.SH) announced today that its holding subsidiary, livzon pharmaceutical group inc. (referred to as livzon group), and its holding subsidiary, 上海 livzon pharmaceutical co., ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration (Certificate No.: 2024S02341). The company's indication for the injection of acetic acid pruline microspheres has been approved for registration for the new indication of "endometriosis".

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする